[These CPE sessions will be presented live* on Zoom. They will be recorded and made available on-demand after the conference as well for those not able to attend live]

 

8:00AM-9:00AM : UNDERSTANDING THE EVOLUTION AND IMPACT OF TELEPHARMACY AT A REMOTE DISPENSING SITE PHARMACY*

Jessica Adams, PharmD

Learning Objectives:  

1. Explain the history of telepharmacy and the evolution of the practice in the U.S. 
2. Describe the workflow and the scope of practice for pharmacists and technicians at a remote dispensing site pharmacy. 
3. Discuss the combination of software and hardware utilized in telepharmacy solutions. 
4. Identify the basics of inventory management, ordering, and controls at a remote dispensing site pharmacy.
   

Level: General Interest | Audience: Pharmacists & Technicians | Topic: Remote Dispensing | CPE Hours: 1.0 

ACPE UAN: 0100-0000-22-145-H99-P/T

 

9:05AM-10:35AM : TREATMENT OF OPIOID USE DISORDER*

Steven Wright, MD

Pharmacist Learning Objectives:

1. Describe the diagnosis of OUD. 
2. Discuss non-pharmacologic treatment of OUD.
3. Discuss pharmacologic treatment for patients with OUD.
4. Describe integrating treatments for patients with OUD.

Technician Learning Objectives:

1. Define OUD. 
2. List non-pharmacologic treatment of OUD.
3. List pharmacologic treatment of OUD.

Level: Intermediate | Audience: Pharmacists & Technicians | Topic: Opioid/SUD | CPE Hours: 1.5 

ACPE UAN: 0100-0000-22-146-H08-P/T 

10:40AM-11:40AM : UPDATES ON TREATMENTS TO QUIT E-CIGARETTES

Jing Li, PharmD, BCPS

Learning Objectives:  

1. Describe the risks versus benefits in using e-cigarettes.
2. Identify the long-term effect of e-cigarettes on a user.
3. List the treatment options based off the current evidence-based recommendations for e-cigarette cessation.

Level: General Interest | Audience: Pharmacists & Technicians | Topic: Tobacco Cessation | CPE Hours: 1.0 

TACPE UAN: 0100-0000-22-147-L01-P/T

 

12:05PM-1:05PM : IMPLEMENTING A TOBACCO CESSATION COLLABORATIVE PRACTICE AGREEMENT

Ryan Gries, PharmD, BCPS, BC-ADM; Alejandro Vazquez, PharmD

Pharmacist Learning Objectives:

1. Define the pharmacist's role in tobacco cessation.
2. Identify the settings in which a pharmacist can perform tobacco cessation.
3. Summarize the items necessary to develop a comprehensive Collaborative Practice Agreement (CPA).
4. Explain the non-pharmacological and pharmacological methods used in tobacco cessation.

Technician Learning Objectives:

1. Describe the importance of tobacco cessation. 
2. Identify the settings in which a pharmacist can perform tobacco cessation.
3. Discuss the available types of tobacco.

Level: General Interest | Audience: Pharmacists & Technicians | Topic: Tobacco Cessation | CPE Hours: 1.0 

ACPE UAN: 0100-0000-22-148-L99-P/T

 

1:10PM-2:10PM : AUTOMATED DISPENSING CABINETS AND HUMAN FACTORS ENGINEERING; A LOOK AT DESIGNING SAFE INTERFACES BETWEEN PEOPLE AND MACHINE

Lukas Westendorf, PharmD, MBA

Learning Objectives: 

1. Define Human Factors Engineering (HFE) and its importance with healthcare technology systems. 
2. Evaluate Automated Dispensing Cabinet (ADC) safety guidelines and standards.
3. Apply ADC guidelines to HFE to prevent serious medication errors. 

Level: Intermediate | Audience: Pharmacists & Technicians | Topic: Patient Safety | CPE Hours: 1.0 

ACPE UAN: 0100-0000-22-149-L05-P/T

 

2:15PM-3:15PM : TWO PUBLIC HEALTH EMERGENCIES IN 2022 - WHAT YOU NEED TO KNOW ABOUT VACCINE RECOMMENDATIONS AND STRATEGIES FOR COVID-19 AND MONKEYPOX

Holly Van Lew, PharmD, BCPS; Andrew DeMotto, PharmD, BCPS. NCPS

Pharmacist Learning Objectives: 

1. Describe the current COVID-19 vaccine recommendations, including the newest bivalent vaccine booster dose recommendations. 
2. Summarize the epidemiology of the 2022 U.S. Monkeypox Outbreak and the at-risk groups for monkeypox infection. 
3. Distinguish between the monkeypox vaccine indications and properly identify at-risk groups and populations. 

Technician Learning Objectives:  

1. Identify the age groups that are authorized for the bivalent COVID-19 boosters. 
2. Discuss the storage and handling of the bivalent booster products and the dose preparation steps. 
3. Describe the appropriate paperwork that should be provided or offered to a patient in advance of a vaccination. 

Level: Advanced | Audience: Pharmacists & Technicians | Topic: Immunization | CPE Hours: 1.0 

ACPE UAN: 0100-0000-22-150-L06-P/T

 

3:20PM-4:20PM : 2022 LEGISLATIVE SESSION UPDATE

Kelly Fine, RPh, FAzPA 

Learning Objectives:  

1. List the AzPA bills that passed during the 2022 Legislative Session.
2. Discuss the impact of the new bills on pharmacy practice.
3. Identify opportunities to get more involved in AzPA’s advocacy efforts. 

Level: General Interest | Audience: Pharmacists & Technicians | Topic: Law | CPE Hours: 1.0 

ACPE UAN: 0100-0000-22-151-L03-P/T 

 

*Due to speaker scheduling conflicts these sessions have been pre-recorded and played live during the conference and therefore attendees will receive home study credit. 

[These CPE programs have been previously offered at AzPA Conferences -If you have already claimed credit for these CPE sessions already you will not be able to claim credit again]

 

MEDICATION ASSISTED TREATMENT FOR OPIOID USE DISORDER (On-Demand)

Brenna Darling, PharmD; Christopher Edwards, PharmD, BCPS 

Learning Objectives: (Pharmacists Only) 

1. Identify characteristics of opioid use disorder and symptoms of opioid withdrawal. 
2. Give examples of appropriate counseling points for patients initiating medication assisted treatment for opioid use disorder. 
3. Summarize requirements and regulations pertaining to the prescription and administration of buprenorphine, methadone, naltrexone, and naloxone. 

Level: Intermediate | Audience: Pharmacists | Topic: Opioids | CPE Hours: 1.0
ACPE UAN: 0100-0000-22-018-H08-P  

Previously offered live at the 2022 AzPA Annual Convention

 

IMMUNIZATION UPDATE: WHAT'S NEW IN 2022? (On-Demand)

Holly Van Lew, PharmD, BCPS; Sophia Galloway, PharmD, BCACP 

Pharmacist Learning Objectives:  

1. Discuss recent updates to pneumococcal vaccine recommendations from the Advisory Committee on Immunization Practices (ACIP) and the Centers for Disease Control and Prevention (CDC), including new products and spacing guidelines. 
2. Identify age indications and co-morbidities that qualify candidates to receive a pneumococcal vaccine. 
3. Discuss expanded in Shingrix indications, Hepatitis B universal recommendations for individuals less than 60-years of age and additional CDC vaccine updates for 2022. 

Technician Learning Objectives:  

1. Identify the storage and handling conditions of the various Pneumococcal, Hepatitis B and Shingrix vaccines. 
2. Recognize the appropriate dose and route of the various Pneumococcal, Hepatitis B and Shingrix vaccines. 
3. Discuss common post-vaccination side effects that can occur after receiving various Pneumococcal, Hepatitis B and Shingrix vaccines. 

Level: Intermediate | Audience: Pharmacists & Technicians | Topic: Immunization | CPE Hours: 1.0
ACPE UAN: 0100-0000-22-027-H06-P/T  

Previously offered live at the 2022 AzPA Annual Convention

 

RAPID FIRE OPIOID UPDATE 

Melinda Burnworth, PharmD, FASHP, FAzPA, BCPS; Christopher Edwards, PharmD, BCPS; Amy Kennedy, PharmD, BCACP, FAPhA 

Pharmacist Learning Objectives:  

1. Summarize current Opioid laws. 
2. Discuss Naloxone administration and dispensing best practices. 
3. Describe updates in the use of opioids and alternative treatments in emergency medicine. 
4. Discuss updates in acute opioid use in the hospital general medicine unit. 

Technician Learning Objectives:  

1. Summarize current Opioid laws. 
2. Discuss Naloxone dispensing guidelines. 
3. List opioid and alternatives used in health systems. 

Level: General Interest | Audience: Pharmacists & Technicians | Topic: Opioids | CPE Hours: 1.25
ACPE UAN: 0100-0000-22-034-L08-P/T  

Previously offered live at the 2022 AzPA Annual Convention

 

Cannabis, In the Weeds (Community, Clinical, and the Courtroom)
Mark Boesen, PharmD, JD; Steve Dudley, PharmD, DABAT; Eman Kirolos, PharmD 

Pharmacist Learning Objectives: 

1. Discuss the changing landscape of cannabis and implications on safety and marketing. 
2. Identify relevant clinical evidence and considerations for the use of cannabis in treating chronic conditions. 
3. Differentiate the regulatory oversight of cannabis and opioids at the Federal and State level. 
4. Discuss the implications of Prop 207 in Arizona. 

Technician Objectives: 

1. Discuss the changing landscape of cannabis and implications on safety and marketing. 
2. Define the applicable cannabis terms. 
3. List the approved and unapproved cannabis products. 
4. Differentiate the regulatory oversight of cannabis and opioids at the Federal and State level. 
5. Discuss the implications of Prop 207 in Arizona. 

Level: General Interest | Audience: Pharmacists & Technicians | Topic: Opioids | CPE Hours: 1.5
ACPE UAN: 0100-0000-21-054-H08-P/T 

Previously offered live at the 2021 AzPA Annual Convention